Prenatal Screening Markers for Down Syndrome: Sensitivity, Specificity, Positive and Negative Expected Value Method

BACKGROUND: Genetic screening for chromosomopathy is performed in the first trimester of pregnancy by determining fetal nuchal translucency (NT), and the pregnancy associated plasma protein-A (PAPP-A) and free human chorionic gonadotropin (free-beta HCG) biomarkers in maternal serum. METHODS: We tes...

Descripción completa

Detalles Bibliográficos
Autores principales: Durković, Jasmina, Ubavić, Milan, Durković, Milica, Kis, Tibor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sciendo 2018
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6294102/
https://www.ncbi.nlm.nih.gov/pubmed/30581343
http://dx.doi.org/10.1515/jomb-2017-0022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6294102/
https://www.ncbi.nlm.nih.gov/pubmed/30581343
http://dx.doi.org/10.1515/jomb-2017-0022

Ejemplares similares